These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33771286)

  • 41. A multi-site comparison of psychosocial approaches for the treatment of methamphetamine dependence.
    Rawson RA; Marinelli-Casey P; Anglin MD; Dickow A; Frazier Y; Gallagher C; Galloway GP; Herrell J; Huber A; McCann MJ; Obert J; Pennell S; Reiber C; Vandersloot D; Zweben J;
    Addiction; 2004 Jun; 99(6):708-17. PubMed ID: 15139869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV.
    Sun-Suslow N; Saloner R; Serrano V; Umlauf A; Morgan EE; Ellis RJ; Letendre S; Grant I; Heaton RK
    AIDS Behav; 2020 Nov; 24(11):3071-3082. PubMed ID: 32274672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structural, functional and spectroscopic MRI studies of methamphetamine addiction.
    Salo R; Fassbender C
    Curr Top Behav Neurosci; 2012; 11():321-64. PubMed ID: 22094881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protocol for a systematic review of psychological treatment for methamphetamine use: an analysis of methamphetamine use and mental health symptom outcomes.
    Stuart A; Baker AL; Bowman J; McCarter K; Denham AMJ; Lee N; Colyvas K; Dunlop A
    BMJ Open; 2017 Sep; 7(9):e015383. PubMed ID: 28882907
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
    Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
    Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Community-based harm reduction substance abuse treatment with methamphetamine-using men who have sex with men.
    Carrico AW; Flentje A; Gruber VA; Woods WJ; Discepola MV; Dilworth SE; Neilands TB; Jain J; Siever MD
    J Urban Health; 2014 Jun; 91(3):555-67. PubMed ID: 24744105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug court treatment for methamphetamine dependence: treatment response and posttreatment outcomes.
    Marinelli-Casey P; Gonzales R; Hillhouse M; Ang A; Zweben J; Cohen J; Hora PF; Rawson RA;
    J Subst Abuse Treat; 2008 Mar; 34(2):242-8. PubMed ID: 17596903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The deleterious effects of methamphetamine use on initial presentation and clinical outcomes in aneurysmal subarachnoid hemorrhage.
    Beadell NC; Thompson EM; Delashaw JB; Cetas JS
    J Neurosurg; 2012 Oct; 117(4):781-6. PubMed ID: 22920957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alteration of Brain Structure With Long-Term Abstinence of Methamphetamine by Voxel-Based Morphometry.
    Zhang Z; He L; Huang S; Fan L; Li Y; Li P; Zhang J; Liu J; Yang R
    Front Psychiatry; 2018; 9():722. PubMed ID: 30618890
    [No Abstract]   [Full Text] [Related]  

  • 50. Duration of detection of methamphetamine in hair after abstinence.
    Suwannachom N; Thananchai T; Junkuy A; O'Brien TE; Sribanditmongkol P
    Forensic Sci Int; 2015 Sep; 254():80-6. PubMed ID: 26197350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.
    Wang L; Min JE; Krebs E; Evans E; Huang D; Liu L; Hser YI; Nosyk B
    Int J Drug Policy; 2017 Nov; 49():32-40. PubMed ID: 28888099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
    Shoptaw S; Heinzerling KG; Rotheram-Fuller E; Steward T; Wang J; Swanson AN; De La Garza R; Newton T; Ling W
    Drug Alcohol Depend; 2008 Aug; 96(3):222-32. PubMed ID: 18468815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology.
    Sim T; Simon SL; Domier CP; Richardson K; Rawson RA; Ling W
    J Addict Dis; 2002; 21(1):75-89. PubMed ID: 11831502
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methamphetamine dependence and neuropsychological functioning: evaluating change during early abstinence.
    Simon SL; Dean AC; Cordova X; Monterosso JR; London ED
    J Stud Alcohol Drugs; 2010 May; 71(3):335-44. PubMed ID: 20409426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Patterns of Cocaine Use During Treatment: Associations With Baseline Characteristics and Follow-Up Functioning.
    Roos CR; Nich C; Mun CJ; Mendonca J; Babuscio TA; Witkiewitz K; Carroll KM; Kiluk BD
    J Stud Alcohol Drugs; 2019 Jul; 80(4):431-440. PubMed ID: 31495380
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
    Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
    Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting addiction severity index (ASI) among clients enrolled in methadone maintenance treatment (MMT) program in Myanmar.
    Tun S; Vicknasingam B; Singh D
    Harm Reduct J; 2021 Aug; 18(1):84. PubMed ID: 34353331
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.
    Durham RC; Chambers JA; Power KG; Sharp DM; Macdonald RR; Major KA; Dow MG; Gumley AI
    Health Technol Assess; 2005 Nov; 9(42):1-174. PubMed ID: 16266559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder.
    Ling W; Chang L; Hillhouse M; Ang A; Striebel J; Jenkins J; Hernandez J; Olaer M; Mooney L; Reed S; Fukaya E; Kogachi S; Alicata D; Holmes N; Esagoff A
    Addiction; 2014 Sep; 109(9):1489-500. PubMed ID: 24825486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.